Lax SF, Horn LC, Löning T. Categorization of uterine cervix tumors: what’s new in the 2014 WHO classification. Pathologe. 2016;37:573–84.

Article  CAS  PubMed  Google Scholar 

Stolnicu S, Barsan I, Hoang L, Patel P, Terinte C, Pesci A, Aviel-Ronen S, Kiyokawa T, Alvarado-Cabrero I, Pike MC, Oliva E. International endocervical adenocarcinoma criteria and classification [IECC]: a new pathogenetic classification for invasive adenocarcinomas of the endocervix. Am J Surg Pathol. 2018;42(2):214–26.

Article  PubMed  PubMed Central  Google Scholar 

Wong RW, Ng JH, Han KC, Leung YP, Shek CM, Cheung KN, Choi CK, Tse KY, Ip PP. Cervical carcinomas with serous-like papillary and micropapillary components: illustrating the heterogeneity of primary cervical carcinomas. Mod Pathol. 2021;34(1):207–21.

Article  CAS  PubMed  Google Scholar 

Prat J, D’Angelo E (2022) Diagnostic challenges in endocervical adenocarcinoma. In: Recent advances in histopathology-25, vol 25: pp. 85.

Han LM, Weiel JJ, Longacre TA, Folkins AK. DICER1-associated tumors in the female genital tract: molecular basis, clinicopathologic features, and differential diagnosis. Adv Anat Pathol. 2022;29(5):297–308.

CAS  PubMed  Google Scholar 

Singh N, McCluggage WG, Gilks CB. High-grade serous carcinoma of tubo-ovarian origin: recent developments. Histopathology. 2017;71(3):339–56.

Article  PubMed  Google Scholar 

Urick ME, Bell DW. Clinical actionability of molecular targets in endometrial cancer. Nat Rev Cancer. 2019;19(9):510–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kitade S, Ariyoshi K, Taguchi K, Maenohara S, Tomita Y, Sonoda K, Okadome M, Saito T. Serous carcinoma of the uterine cervix: clinicopathological features differing from serous carcinomas of other female organs. J Obstet Gynaecol Res. 2020;46(1):153–60. https://doi.org/10.1111/jog.14142.

Article  CAS  PubMed  Google Scholar 

Hong JA, Kim TH, Lee HH, Chung SH, Heo GE, Jeon DS, Kwak JJ, Do Choi S, Han E. Uterine serous adenocarcinoma in an elderly postmenopausal woman: clinically misdiagnosed as uterine cervix cancer. J Menopausal Med. 2015;21(3):171.

Article  PubMed  PubMed Central  Google Scholar 

Jonska-Gmyrek J, Zolciak-Siwinska A, Gmyrek L, Michalski W, Poniatowska G, Fuksiewicz M, Wiechno P, Kucharz J, Kowalska M, Kotowicz B. Serous carcinoma of the uterine cervix, an extremely rare aggressive entity: a literature review. Gynecol Obstet Invest. 2018;83(3):220–6.

Article  CAS  PubMed  Google Scholar 

Herrera Gómez RG, Hastir D, Liapi A, Dolcan A, Herrera FG, Mathevet P, Sarivalasis A. So-called serous carcinoma of the uterine cervix with BRCA2 mutation: case report and review of the literature. Case Rep Oncol. 2021;14(3):1792–8. https://doi.org/10.1159/000520429.

Article  PubMed  PubMed Central  Google Scholar 

Zhang W, Gao Y, Zhang W, Lin Z, Bi H, Zhu L. Survival outcomes and prognostic factors of papillary serous adenocarcinoma and papillary squamous cell carcinoma of the uterine cervix. J Obstet Gynaecol. 2022;42(5):1233–8.

Article  CAS  PubMed  Google Scholar 

Lee JE, Chung Y, Rhee S, Kim TH. Untold story of human cervical cancers: HPV-negative cervical cancer. BMB Rep. 2022;55(9):429–38. https://doi.org/10.5483/BMBRep.2022.55.9.042.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Giannella L, Di Giuseppe J, DelliCarpini G, Grelloni C, Fichera M, Sartini G, Caimmi S, Natalini L, Ciavattini A. HPV-negative adenocarcinomas of the uterine cervix: from molecular characterization to clinical implications. Int J Mol Sci. 2022;23(23):15022. https://doi.org/10.3390/ijms232315022.

Article  PubMed  PubMed Central  Google Scholar 

Bao H, Zhao Y, Zhang X, Bi H, Cong S, Fang L, Wang HJ, Wang L. HPV-negative high-grade cervical precancerous lesions or invasive cancer in China: a post hoc analysis of a multicentric clinical study. Int J Gynaecol Obstet. 2023;161(1):159–67. https://doi.org/10.1002/ijgo.14598.

Article  CAS  PubMed  Google Scholar